Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05963659
Other study ID # 20230630
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 10, 2023
Est. completion date August 7, 2024

Study information

Verified date January 2024
Source Peking University Sixth Hospital
Contact Xiangxue li
Phone +8613719234046
Email 2011210552@bjmu.edu.cn
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Alcohol use is increasingly prevalent in modern society and is known to cause cognitive impairment and dysregulation of inflammatory responses. In the present study, the investigators want to perform a randomised controlled trials to test whether nitrate could change the oral microbiota and benefit the cognitive impairment in alcohol dependence patients. The investigators survey the oral bacterial communities in saliva samples of 70 alcohol dependent patients following 14 days of dietary inorganic nitrate (nitrate-rich beetroot juice, ~750 mg NO3- /d) and placebo (nitrate-depleted beetroot juice, ~1 mg NO3- /d) supplementation.


Recruitment information / eligibility

Status Recruiting
Enrollment 70
Est. completion date August 7, 2024
Est. primary completion date August 7, 2024
Accepts healthy volunteers No
Gender Male
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria: 1. Han nationality 2. Montreal Cognitive Assessment(MoCA) score >11 3. Diagnosis of alcohol dependence Exclusion Criteria: 1. Past or current infectious disease 2. Past or current heart, brain, liver, kidney, and other severe diseases 3. Past or current metabolic diseases that can lead to abnormalities of the immune system, such as obesity (Body Mass Index > 30 kg/m2), diabetes, or rheumatoid arthritis 4. Past or current neurodegenerative diseases, such as Parkinson's disease 5. Use of steroidal and non-steroidal anti-inflammatory drugs, antibiotics, antioxidants, and immunosuppressive agents within two months of enrollment 6. Use of probiotics and probiotics every day for the first two months before enrollment 7. Previous or current DSM-IV diagnosis of schizophrenia, depression, anxiety disorder, bipolar disorder, mental retardation, dementia (excluding mild cognitive impairment, MCI), or substance dependence other than alcohol and nicotine 8. Irregular eating habits that affect the oral flora (except alcohol) in the previous two months 9. Current oral disease

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
nitrate-rich beetroot juice
nitrate-rich beetroot juice, ~750 mg NO3- /d
nitrate-depleted beetroot juice
nitrate-depleted beetroot juice, ~1 mg NO3- /d

Locations

Country Name City State
China Anhui mental health center Hefei Anhui

Sponsors (1)

Lead Sponsor Collaborator
Peking University Sixth Hospital

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Other Systolic and diastolic blood pressure Test by blood pressure monitor baseline and post-intervention (two weeks after baseline test)
Other Cytokine Tumor Necrosis Factor-a in serum The collected serum samples were used to test the levels of TNF-a by Enzyme-Linked Immunosorbent Assay baseline and post-intervention(two weeks after baseline test)
Other The blood biochemical related parameters includes liver enzymes (alanine aminotransferase and aspartate aminotransferase) The collected venous blood were sent to the department of clinical laboratory and the investigators recorded the laboratory report. baseline and post-intervention (two weeks after baseline test)
Other The blood biochemical related parameters blood fat (cholesterol, triglycerides, low density lipoprotein and high density lipoprotein The collected venous blood were sent to the department of clinical laboratory and the investigators recorded the laboratory report. baseline and post-intervention (two weeks after baseline test)
Other Cytokine Interleukin-1b in serum The collected serum samples were used to test the levels of IL-1b by Enzyme-Linked Immunosorbent Assay baseline and post-intervention(two weeks after baseline test)
Other Cytokine Interleukin-6 in serum The collected serum samples were used to test the levels of IL-6 by Enzyme-Linked Immunosorbent Assay baseline and post-intervention (two weeks after baseline test)
Other Cytokine Interleukin-10 in serum The collected serum samples were used to test the levels of IL-10 by Enzyme-Linked Immunosorbent Assay baseline and post-intervention (two weeks after baseline test)
Primary Changes of Delayed Match to Sample Percent Correct (all delays) from baseline to post-intervention Test by DMS-PCAD (Delayed Match to Sample Percent Correct , all delays) baseline and post-intervention(two weeks after baseline test)
Primary Changes of Spatial Working Memory Between Errors from baseline to post-intervention Test by SWM-BE (The Spatial Working Memory Between Errors ) baseline and post-intervention(two weeks after baseline test)
Secondary Changes of oral microbiota from baseline to post-intervention Saliva samples were used to test the composition of microbiota by 16S RNA sequencing. baseline and post-intervention(two weeks after baseline test)
Secondary Changes of gut microbiota from baseline to post-intervention Feces samples were used to test the composition of microbiota by 16S RNA sequencing. baseline and post-intervention(two weeks after baseline test)
Secondary Changes of Delayed Match to Sample Percent Correct (0 seconds delay) from baseline to post-intervention Test by Delayed Match to Sample Percent Correct (0 seconds delay) baseline and post-intervention(two weeks after baseline test)
Secondary Changes of Delayed Match to Sample Percent Correct (4 seconds delay) from baseline to post-intervention Test by Delayed Match to Sample Percent Correct (4 seconds delay) baseline and post-intervention(two weeks after baseline test)
Secondary Changes of Delayed Match to Sample Percent Correct (12 seconds delay) from baseline to post-intervention Test by Delayed Match to Sample Percent Correct (12 seconds delay) baseline and post-intervention(two weeks after baseline test)
Secondary Changes of Spatial Working Memory errors 4 boxes from baseline to post-intervention Test by The Spatial Working Memory errors 4 boxes baseline and post-intervention(two weeks after baseline test)
Secondary Changes of Spatial Working Memory errors 6 boxes from baseline to post-intervention Test by The Spatial Working Memory errors 6 boxes baseline and post-intervention(two weeks after baseline test)
Secondary Changes of Spatial Working Memory errors 8 boxes from baseline to post-intervention Test by The Spatial Working Memory errors 8 boxes baseline and post-intervention(two weeks after baseline test)
Secondary Changes of Intra-Extra Dimensional Set Shift test Stages Completed from baseline to post-intervention Test by The Intra-Extra Dimensional Set Shift test Stages Completed baseline and post-intervention(two weeks after baseline test)
Secondary Changes of Intra-Extra Dimensional Completed Stage Errors from baseline to post-intervention Test by The Intra-Extra Dimensional Completed Stage Errors baseline and post-intervention(two weeks after baseline test)
Secondary Changes of Cambridge Gambling Task Risk Adjustment Merged: Risk adjustment from baseline to post-intervention Test by Cambridge Gambling Task Risk Adjustment Merged: Risk adjustment baseline and post-intervention(two weeks after baseline test)
Secondary Changes of Cambridge Gambling Decision Making Quality Total Merged from baseline to post-intervention Test by Cambridge Gambling Decision Making Quality Total Merged baseline and post-intervention(two weeks after baseline test)
Secondary Changes of Cambridge Gambling Delay Aversion Total from baseline to post-intervention Test by Cambridge Gambling Delay Aversion Total baseline and post-intervention(two weeks after baseline test)
Secondary Changes of Reaction Time Median Five-Choice Movement Time from baseline to post-intervention Test by Reaction Time Median Five-Choice Movement Time baseline and post-intervention(two weeks after baseline test)
Secondary Changes of Reaction Time Median Five-Choice Reaction Time from baseline to post-intervention Test by Reaction Time Median Five-Choice Reaction Time baseline and post-intervention(two weeks after baseline test)
Secondary Changes of Rapid Visual Information Processing test Probability of False Alarm from baseline to post-intervention Test by the Rapid Visual Information Processing test Probability of False Alarm baseline and post-intervention(two weeks after baseline test)
Secondary Changes of Rapid Visual Information Processing test A prime from baseline to post-intervention Test by the Rapid Visual Information Processing test A prime baseline and post-intervention(two weeks after baseline test)
Secondary Changes of Rapid Visual Information Processing test Median Response Latency from baseline to post-intervention Test by the Rapid Visual Information Processing test Median Response Latency baseline and post-intervention(two weeks after baseline test)
Secondary Changes of nitrate levels in serum from baseline to post-intervention The collected serum samples were used to test the levels of nitrate and nitrite by High Performance Liquid Chromatography \ HPLC baseline and post-intervention(two weeks after baseline test)
Secondary Changes of nitrite levels in serum from baseline to post-intervention The collected serum samples were used to test the levels of nitrate and nitrite by High Performance Liquid Chromatography \ HPLC baseline and post-intervention(two weeks after baseline test)
See also
  Status Clinical Trial Phase
Completed NCT02901041 - Interdisciplinary Study of A Novel Anticonvulsant in Alcoholism Phase 3
Completed NCT03340051 - Remote Alcohol Monitoring and Episodic Thinking N/A
Not yet recruiting NCT06444243 - Psilocybin-assisted Therapy for Alcohol Use Disorder Phase 2
Completed NCT02705898 - Lifestyle Physical Activity Intervention for Depressed Alcohol Dependent Women N/A
Completed NCT02486900 - Neurofeedback & Alcohol Dependence N/A
Completed NCT02197598 - Treatment of Patients Suffering of Alcohol Dependence and Impaired Liver Function With Selincro® As-needed Use Phase 4
Completed NCT02179749 - Mifepristone Treatment of Alcohol Use Disorder Phase 2
Recruiting NCT02385643 - The Efficacy of A Smartphone-based Support System to Reinforce Alcohol Abstinence in Treatment-seeking Patients N/A
Completed NCT01828866 - Eye Movement Desensitization and Reprocessing (EMDR) in Alcohol Dependent Patients N/A
Terminated NCT01408641 - Topiramate for Alcohol Use in Posttraumatic Stress Disorder N/A
Active, not recruiting NCT01182766 - New Treatment for Alcohol and Nicotine Dependence Phase 2/Phase 3
Completed NCT02193204 - Chronic Alcohol, Stress Inflammatory Response and Relapse Risk N/A
Completed NCT01342549 - Treatment Strategy for Alcohol Use Disorders in Veterans With TBI Phase 3
Completed NCT01176591 - HBPL Study of the Impact of the NK1 Antagonist Aprepitant Phase 2
Completed NCT01165541 - A Study of Quetiapine and Mirtazapine for the Treatment of Alcohol Dependency Phase 2
Completed NCT00585780 - Prazosin to Reduce Stress-Induced Alcohol/Drug Craving and Relapse Phase 1/Phase 2
Completed NCT01056484 - Mindfulness Meditation for Health Phase 2
Completed NCT00607620 - Disseminating Organizational SBI Services at Trauma Centers N/A
Completed NCT00884884 - Aripiprazole and Topiramate on Free-Choice Alcohol Use Phase 2/Phase 3
Completed NCT00463346 - Treatment With Acamprosate in Patients With Schizophrenia and Comorbid Alcoholism Phase 3